07:00 , Jul 21, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Cell division cycle 34 homolog (CDC34); S-phase kinase-associated protein 2 (SKP2) An in vitro study suggests inhibiting CDC34 could help treat cancer. An in...
07:00 , Jul 21, 2011 |  BC Innovations  |  Targets & Mechanisms

Celgene skips SKP2

Celgene Corp....